Skip to main content
OpenTrials
Completed

NCT Number: NCT06845384

Registry of Acute Coronary Syndrome in the Regional Cardiovascular Center

The study is a prospective registry of patients consequently admitted to the regional cardiovascular center with a diagnosis of acute coronary syndrome, in order to study the behavior of patients from the first minutes of the onset of the anginal syndrome, and influence of the delay in calling of ambulance on short-term and long-term outcomes of the disease. Other factors which may influence short-term and long-term outcomes will also be assessed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Аcute Coronary Syndrome Acute Coronary Syndrome Angina Pectoris Angina, Unstable Cardiovascular Diseases Chest Pain Heart Diseases Myocardial Ischemia Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

National Medical Research Centre for Therapy and Preventive Medicine

Moscow, 101990, Russia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women aged 18 and over, permanently residing in the Moscow region and in Moscow.
  • Patients hospitalized in the Regional Vascular Center of Stupino Clinical Hospital (GBUZ MO SKB) with a diagnosis of ACS with and without ST-segment elevation.
  • Signing an informed consent form to participate in the study and the processing of personal data, as well as conducting a telephone survey during the follow-up.

Exclusion criteria

  • The patient's refusal to participate in the study and to allow the use of personal data during the study.
  • The presence of mental illness.
  • The patient plans to leave Russia for permanent or long-term residence.

Treatment and study plan

Primary outcomes

  1. all-cause mortality

    Time frame: 1 year and 3 years

Secondary outcomes

  1. Сombined secondary end-point

    Time frame: 1 year and 3 years

    Rate of nonfatal myocardial infarction, nonfatal stroke, hospitalization for decompensated heart failure, and emergency invasive cardiac interventions.

Sponsors and collaborators

Lead sponsor

National Medical Research Center for Therapy and Preventive Medicine

Other Gov

Collaborators

  • Stupino Clinical Hospital, Moscow Region State Medical Institution

Registry information

Acronym: STOCS

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Feb 25, 2025
Registry last updated
May 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.